scanX
Home
Jenburkt Pharmaceuticals

Jenburkt Pharmaceuticals

1,199.00
-14.55
(-1.20%)
Market Cap (₹ Cr.)
₹536
52 Week High
1,375.00
Book Value
₹
52 Week Low
660.05
PE Ratio
17.67
PB Ratio
3.39
PE for Sector
49.68
PB for Sector
19.95
ROE
17.92 %
ROCE
23.83 %
Dividend Yield
1.26 %
EPS
₹63.50
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Formulations
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
3.31 %
Net Income Growth
5.69 %
Cash Flow Change
-52.38 %
ROE
-10.89 %
ROCE
-9.60 %
EBITDA Margin (Avg.)
3.00 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
24
23
26
25
23
23
29
26
28
18
38
32
31
24
33
33
36
22
35
34
32
18
32
33
31
28
37
34
30
32
37
36
37
30
39
37
40
34
43
Expenses
18
19
20
19
19
20
22
21
22
21
24
24
22
21
25
26
26
22
27
27
24
17
23
25
25
22
25
26
24
24
27
28
28
22
29
29
29
23
30
EBITDA
6
4
6
6
4
4
8
5
7
-3
13
7
9
4
8
7
10
1
8
8
8
2
8
8
6
7
12
8
6
8
10
8
9
8
10
9
11
11
13
Operating Profit %
18 %
15 %
21 %
20 %
12 %
12 %
24 %
18 %
21 %
-21 %
34 %
21 %
28 %
11 %
22 %
20 %
25 %
-3 %
22 %
20 %
21 %
4 %
24 %
22 %
17 %
20 %
29 %
21 %
16 %
23 %
24 %
20 %
21 %
24 %
24 %
20 %
25 %
29 %
28 %
Depreciation
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
1
1
1
1
1
1
1
1
1
1
1
1
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
5
4
5
5
3
3
7
5
6
-3
13
7
9
3
8
7
9
0
8
7
7
1
8
7
6
6
11
8
5
8
9
8
8
7
10
8
10
10
13
Tax
2
1
2
2
2
1
2
2
3
0
3
2
3
1
2
2
3
0
2
2
2
0
2
1
2
1
3
2
1
2
3
3
2
2
3
3
3
3
3
Net Profit
2
3
3
4
1
2
5
3
4
-3
10
5
6
3
6
5
7
0
6
5
5
1
6
6
4
5
8
6
4
6
7
5
6
5
7
5
8
7
10
EPS in ₹
4.81
5.49
7.38
7.53
2.78
4.19
11.20
6.35
7.60
-6.19
21.45
9.89
12.15
5.88
12.52
9.72
15.02
0.10
12.10
10.11
10.06
2.20
12.36
12.96
8.45
10.13
17.37
13.57
7.51
12.97
14.96
11.84
13.92
12.17
16.59
12.25
17.86
16.80
21.75
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
61
58
76
78
103
104
121
143
142
165
Fixed Assets
12
12
11
10
10
12
11
11
10
10
Current Assets
49
45
64
66
90
90
80
76
81
110
Capital Work in Progress
0
0
0
0
1
0
0
0
1
1
Investments
0
0
2
5
5
4
7
8
11
17
Other Assets
49
46
64
63
87
88
104
123
119
137
Total Liabilities
61
58
76
78
103
104
121
143
142
165
Current Liabilities
24
14
18
13
23
20
18
21
16
16
Non Current Liabilities
4
4
4
3
3
5
5
4
4
4
Total Equity
33
40
54
61
78
80
99
117
122
145
Reserve & Surplus
29
36
50
57
73
75
94
113
118
141
Share Capital
5
5
5
5
5
5
5
5
4
4
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
11
2
1
-1
0
1
0
3
-1
1
Investing Activities
1
-0
-10
1
-11
-3
-19
-1
3
-1
Operating Activities
9
8
10
16
13
15
20
9
17
8
Financing Activities
1
-5
1
-18
-2
-11
-1
-6
-21
-7
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
45.73 %
45.73 %
45.73 %
45.73 %
45.73 %
45.73 %
45.73 %
45.97 %
47.56 %
47.56 %
47.42 %
47.39 %
47.23 %
46.71 %
46.71 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
44.30 %
42.77 %
42.81 %
41.55 %
41.28 %
41.33 %
40.77 %
41.24 %
40.37 %
41.12 %
41.48 %
41.99 %
42.65 %
43.39 %
43.56 %

Dividend History

No dividends have been distributed by the company in the past 10 years

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Torrent Pharmaceuticals
3,421.35 1,15,052.80 66.15 10,785.70 11.59 1,656 17.36 60.00
Gland Pharma
1,824.35 29,316.70 42.40 5,835.00 50.97 773 -15.77 59.49
Eris Lifesciences
1,353.10 18,265.50 52.44 2,033.00 19.85 397 -21.26 39.79
Caplin Point Laboratories
2,399.10 18,221.10 36.94 1,761.00 15.65 461 12.66 60.93
Sai Life Sciences
746.05 15,870.60 191.85 1,494.30 20.01 83 - -
Marksans Pharma
290.20 13,313.10 38.34 2,227.80 16.55 315 16.71 36.40
Shilpa Medicare
765.35 7,497.10 130.49 1,159.80 8.65 32 1,018.75 33.67
Jeena Sikho Lifecare
2,163.35 5,615.20 168.18 207.30 40.07 34 - 51.59
Ajanta Pharma
2,790.90 3,325.80 39.99 4,293.30 11.77 816 10.86 38.75
Windlas Biotech
1,048.75 2,156.10 35.28 644.40 23.21 58 12.14 50.41

Corporate Action

Technical Indicators

RSI(14)
Neutral
44.73
ATR(14)
Less Volatile
61.11
STOCH(9,6)
Neutral
30.36
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-15.85
ADX(14)
Weak Trend
18.21
UO(9)
Bearish
46.08
ROC(12)
Downtrend And Accelerating
-5.10
WillR(14)
Oversold
-94.60
Bearish
4
Neutral
4
Bullish
1
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Price & Volume Screeners
Intraday Screeners
Candlestick Screeners
Fundamental Screeners
Technical Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.